FDA Inspection 706673 — MEDOX Corporation

MEDOX Corporation — FEI 1036301

The FDA completed an inspection of MEDOX Corporation on Jan 20, 2011 in Sarasota, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 20, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sarasota, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
149521 CFR 211.122(a)Written procedures describing in detail
200721 CFR 211.186(a)Signature and checking of records -- 2 persons